Global Lab Automation In Protein Engineering Market Industry Market Size, Share and Growth Analysis Report - Forecast Trends and Outlook 2026-2030

The lab automation in protein engineering market encompasses instruments, reagents, software, and services that automate workflows for protein design, expression, purification, and characterization. The overall lab automation market was valued at approximately $5.41 billion in 2025, while the wider protein engineering market reached roughly $2.6 billion in 2023 and is on a steeper growth trajectory. Automation in this space spans liquid handling systems, robotic workcells, integrated purification platforms, and analytical instrumentation designed to accelerate discovery cycles.

• •Lab automation market valued at $5.41 billion in 2025, projected to reach $7.67 billion by 2030 at 7.25% CAGR
• •Broader protein engineering market grew from $2.6 billion (2023) to an estimated $7.6 billion by 2030
• •Generative AI-assisted protein design market rising from $1.54 billion in 2025 to $4.94 billion in coming years

The biopharmaceutical industry's expanding pipeline of biologic drugs and antibody therapeutics is a primary driver, as protein engineering underpins the development of most next-generation medicines. Advances in computational methods, including generative AI and machine learning for protein structure prediction, are dramatically accelerating design cycles and making automation essential for handling increased throughput. Additional demand stems from synthetic biology applications, food and detergent enzyme engineering, and environmental biocatalyst development.

• •Biopharma pipeline growth fueling demand for automated protein expression and screening platforms
• •Generative protein design and AI-driven tools expanding the addressable market beyond traditional R&D
• •Growth in synthetic biology and industrial enzyme applications broadening end-user base

The market is typically segmented by product type into instruments, reagents, and software/services, with instruments representing the largest share due to the high capital cost of automated platforms. Key application areas include medical and biopharmaceuticals, food and detergent industries, environmental biotechnology, and biopolymer production. North America leads the market, supported by substantial R&D investment and a dense concentration of biotech firms, while Europe and the Asia-Pacific region, particularly China and India, are the fastest-growing markets.

• •Product segmentation: instruments dominate, followed by reagents and software/services
• •Primary applications: medical/biopharmaceuticals, food and detergent enzymes, environmental and biopolymer sectors
• •North America leads globally, with Asia-Pacific as the fastest-expanding regional market

What are the recent trends and outlook?

Integration of artificial intelligence and machine learning with laboratory automation systems is the most transformative trend, enabling closed-loop experimentation where automated platforms can design, test, and refine protein variants with minimal human intervention. Cloud-based lab informatics and data management platforms are gaining traction as datasets from automated workflows grow exponentially. The convergence of generative protein design with physical automation is expected to sustain above-market growth rates and reshape R&D economics across the biopharmaceutical and industrial biotechnology sectors through 2030 and beyond.

• •AI-integrated closed-loop automation enabling autonomous protein design-build-test cycles
• •Cloud lab informatics and digital twin technologies streamlining workflow orchestration
• •Generative protein design automation projected to outpace the broader lab automation market significantly